Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Session 5 - Patient selection, response and toxicity assessment

Patient selection: Genomic matching to Phase I trials, NGS, ctDNA, existing programmes

Date

03 Feb 2024

Session

Session 5 - Patient selection, response and toxicity assessment

Topics

Translational Research; Genetic and Genomic Testing

Tumour Site

Presenters

Timothy A. Yap, AU

Resources

This content is available to ESMO members and event participants.

Login